QINLOCK 50 MG COMPRIMIDOS
QINLOCK 50 MG COMPRIMIDOS
Commercialized
Register Number
1211569001
Prescription Type
Diagnóstico Hospitalario
Authorization Date
Apr 27, 2023
Dosage Form
COMPRIMIDO
Route: VÍA ORAL
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number1211569001
EMA Approved
Yes
Drug Classification
✗
Generic
No
✓
Orphan
Yes
✗
Biosimilar
No
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (1)
RIPRETINIBActive
Quantity: 50 mg
Name: RIPRETINIB
ATC CLASSIFICATION (3)
L01E
L01EX
L01EX19